Stimulus-secretion coupling in the pancreatic beta-cell

Advances in Experimental Medicine and Biology

Volumn 552, Issue , 2004, Pages 66-90

  Juhl, Kirstine ^a   Hutton, John ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALLOXAN; ARACHIDONIC ACID; AUTOANTIBODY; C PEPTIDE; CALCIUM CHANNEL; CD4 ANTIGEN; CYTOKINE; GAMMA INTERFERON; GLUCAGON; GLUCOSE; GLUCOSE 6 PHOSPHATASE; HOMEODOMAIN PROTEIN; INSULIN; INTERLEUKIN 1BETA; LIPID; LYSOPHOSPHOLIPID; MOLECULAR MOTOR; PHOSPHOLIPASE A2; POTASSIUM CHANNEL; SNARE PROTEIN; SOMATOSTATIN; STREPTOZOCIN; TRANSCRIPTION FACTOR PDX 1; TUMOR NECROSIS FACTOR ALPHA;

ADOPTIVE IMMUNOTHERAPY; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; DISEASE COURSE; GLUCAGON RELEASE; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATORY CELL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN SYNTHESIS; INSULIN TREATMENT; METABOLITE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS FUNCTION; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SUGAR TRANSPORT; T LYMPHOCYTE;

ANIMALS; ARACHIDONIC ACID; DIABETES MELLITUS, TYPE 1; HUMANS; INSULIN; ISLETS OF LANGERHANS; MODELS, BIOLOGICAL; PHOSPHOLIPASES A; SIGNAL TRANSDUCTION;

EID: 11844299072     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (176)

1. Yu L, Rewers M, Gianani R et al. Antiislet autoantibodies usually develop sequentially rather than simultaneously. J Clin Endocrinol Metab 1996; 81(12):4264-4267.
2. Rewers M, Norris JM, Eisenbarth GS et al. Beta-cell autoantibodies in infants and toddlers without IDDM relatives: Diabetes autoimmunity study in the young (DAISY). J Autoimmun 1996; 9(3):405-410.
3. von Herrath MG, Oldstone M, Homann D et al. Is activation of autoreactive lymphocytes always detrimental? Viral infections and regulatory circuits in autoimmunity. Curr Dir Autoimmun 2001; 4:91-122.
4. von Herrath MG, Holz A, Homann D et al. Role of viruses in type I diabetes. Semin Immunol 1998; 10(1):87-100.
5. Bishop, Polak. The Anatomy, Organization and Ultrastructure of the Islets of Langerhans. Textbook of Diabetes. San Diego: Blackwell Science, 1997.
6. Ashcroft FM, Rorsman P. Electrophysiology of pancreatic islet cells. CRC Press Inc., 1995:207-242.
7. Burkitt HG, Young B, Heath JW. Wheater's Functional Histology. 3rd ed. Edinburgh: Churchill Livingstone, 1993.
8. Pierce SB, Costa M, Wisotzkey R et al. Regulation of DAF-2 receptor signaling by human insulin and ins-1, a member of the unusually large and diverse C. elegans insulin gene family. Genes Dev 2001; 15(6):672-686.
9. Leibiger IB, Leibiger B, Moede T et al. Exocytosis of insulin promotes insulin gene transcription via the insulin receptor/PI-3 kinase/p70 s6 kinase and CaM kinase pathways. Mol Cell 1998; 1(6):933-938.
10. Khan FA, Goforth PB, Zhang M et al. Insulin activates ATP-sensitive K(+) channels in pancreatic beta-cells through a phosphatidylinositol 3-kinase-dependent pathway. Diabetes 2001; 50(10):2192-2198.
11. Schuit FC, In't Veld PA, Pipeleers DG. Glucose stimulates proinsulin biosynthesis by a dose-dependent recruitment of pancreatic beta cells. Proc Natl Acad Sci USA 1988; 85(11):3865-3869.
12. Hostens K, Pavlovic D, Zambre Y et al. Exposure of human islets to cytokines can result in disproportionately elevated proinsulin release. J Clin Invest 1999; 104(1):67-72.
13. Eizirik DL, Mandrup-Poulsen T. A choice of death - the signal-transduction of immune-mediated beta- cell apoptosis. Diabetolog 2001; 44(12):2115-2133.
14. Matschinsky FM, Glaser B, Magnuson MA. Pancreatic beta-cell glucokinase: Closing the gap between theoretical concepts and experimental realities. Diabetes 1998; 47(3):307-315.
15. Schuit FC, Huypens P, Heimberg H et al. Glucose sensing in pancreatic beta-cells: A model for the study of otherglucose-regulated cells in gut, pancreas and hypothalamus. Diabetes 2001; 50(1):1-11.
16. Ahren B, Alumets J, Hakanson R et al. Somatostatin, pancreatic polypeptide, substance P and neurotensin. Cellular distribution and effects on stimulated insulin secretion in the mouse. Endocrinology 1979; 104(3):832-838.
17. Szecowka J, Tatemoto K, Rajamaki G et al. Effects of PYY and PP on endocrine pancreas. Acta Physiol Scand 1983; 119(2):123-126.
18. Degano P, Peiro E, Miralles P et al. Effects of rat pancreatic polypeptide on islet-cell secretion in the perfused rat pancreas. Metabolism 1992; 41(3):306-309.
19. Henquin JC. Triggering and amplifying pathways of regulation of insulin secretion by glucose. Diabetes 2000; 49(11):1751-1760.
20. Aguilar-Diosdado M, Parkinson D, Corbett JA et al. Potential autoantigens in IDDM. Expression of carboxypeptidase-H and insulin but not glutamate decarboxylase on the beta-cell surface. Diabetes 1994; 43(3):418-425.
21. Rabinovitch A, Pukel C, Baquerizo H. Interleukin-1 inhibits glucose-modulated insulin and glucagon secretion in rat islet monolayer cultures. Endocrinology 1988; 122(6):2393-2398.
22. Nielsen K, Karlsen AE, Deckert M et al. Beta-cell maturation leads to in vitro sensitivity to cytotoxins. Diabetes 1999; 48(12):2324-2332.
23. Strandell E, Buschard K, Saldeen J et al. Interleukin-1 beta induces the expression of hsp70, heme oxygenase and Mn-SOD in FACS-purified rat islet beta-cells, but not in alpha-cells. Immunol Lett 1995; 48(2):145-148.
24. Horio F, Fukuda M, Katoh H et al. Reactive oxygen intermediates in autoimmune islet cell destruction of the NOD mouse induced by peritoneal exudate cells (rich in macrophages) but not T cells. Diabetolog 1994; 37(1):22-31.
25. Jorns A, Tiedge M, Lenzen S et al. Effect of superoxide dismutase, catalase, chelating agents and free radical scavengers on the toxicity of alloxan to isolated pancreatic islets in vitro. Free Radic Biol Med 1999; 26(9-10):1300-1304.
26. Eizirik DL, Sandler S, Welsh N et al. Interleukin-1 beta-induced stimulation of insulin release in mouse pancreatic islets is related to diacylglycerol production and protein kinase C activation. Mol Cell Endocrinol 1995; 111(2):159-165.
27. Chen MC, Paez-Espinosa V, Welsh et al. Interleukin-1 beta regulates phospholipase D-1 expression in rat pancreatic beta-cells. Endocrinology 2000; 141(8):2822-2828.
28. Karlsen AE, Sparre T, Nielsen K et al. Proteome analysis - A novel approach to understand the pathogenesis of Type 1 diabetes mellitus. Dis Markers 2001; 17(4):205-216.
29. Eizirik DL. Interleukin-1 induced impairment in pancreatic islet oxidative metabolism of glucose is potentiated by tumor necrosis factor. Acta Endocrinol (Copenh) 1988; 119(3):321-325.
30. Miura M, Endo S, Kaku LL et al. Plasma type II phospholipase A2 levels in patients with acute pancreatitis. Res Commun Mol Pathol Pharmacol 2001; 109(3-4):159-164.
31. Uhl W, Schrag HJ, Schmitter N et al. Experimental study of a novel phospholipase A2 inhibitor in acute pancreatitis. Br J Surg 1998; 85(5):618-623.
32. Matschinsky FM. Banting Lecture 1995. A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm. Diabetes 1996; 45(2):223-241.
33. Watada H, Kajimoto Y, Miyagawa J et al. PDX-1 induces insulin and glucokinase gene expressions in alphaTC1 clone 6 cells in the presence of betacellulin. Diabetes 1996; 45(12):1826-1831.
34. Leibiger B, Leibiger IB, Moede T et al. Selective insulin signaling through A and B insulin receptors regulates transcription of insulin and glucokinase genes in pancreatic beta cells. Mol Cell 2001; 7(3):559-570.
35. Magnuson MA. Tissue-specific regulation of glucokinase gene expression. J Cell Biochem 1992; 48(2):115-121.
36. German MS. Glucose sensing in pancreatic islet beta cells: The key role of glucokinase and the glycolytic intermediates. Proc Natl Acad Sci USA 1993; 90(5):1781-1785.
37. Halban PA, Praz GA, Wollheim CB. Abnormal glucose metabolism accompanies failure of glucose to stimulate insulin release from a rat pancreatic cell line (RINm5F). Biochem J 1983; 212(2):439-443.
38. Ferber S, BeltrandelRio H, Johnson JH et al. GLUT-2 gene transfer into insulinoma cells confers both low and high affinity glucose-stimulated insulin release. Relationship to glucokinase activity. J Biol Chem 1994; 269(15):11523-11529.
39. Ling ZC, Khan A, Delauny F et al. Increased glucocorticoid sensitivity in islet beta-cells: Effects on glucose 6-phosphatase, glucose cycling and insulin release. Diabetolog 1998; 41(6):634-639.
40. Khan A, Chandramouli V, Ostenson CG et al. Glucose cycling in islets from healthy and diabetic rats. Diabetes 1990; 39(4):456-459.
41. Giroix MH, Sener A, Malaisse WJ. Hexose metabolism in pancreatic islets. Absence of glucose-6-phosphatase in rat islet cells. Mol Cell Endocrinol 1987; 49(2-3):219-225.
42. Ebert DH, Bischof LJ, Streeper RS et al. Structure and promoter activity of an islet-specific glucose-6- phosphatase catalytic subunit-related gene. Diabetes 1999; 48(3):543-551.
43. Sekine N, Cirulli V, Regazzi R et al. Low lactate dehydrogenase and high mitochondrial glycerol phosphate dehydrogenase in pancreatic beta-cells. Potential role in nutrient sensing. J Biol Chem 1994; 269(7):4895-4902.
44. Giroix MH, Rasschaert J, Sener A et al. Study of hexose transport, glycerol phosphate shuttle and Krebs cycle in islets of adult rats injected with streptozotocin during the neonatal period. Mol Cell Endocrinol 1992; 83(2-3):95-104.
45. Sener A, Malaisse WJ. Hexose metabolism in pancreatic islets. Ca(2+)-dependent activation of the glycerol phosphate shuttle by nutrient secretagogues. J Biol Chem 1992; 267(19):13251-13256.
46. Farfari S, Schulz V, Corkey B et al. Glucose-regulated anaplerosis and cataplerosis in pancreatic beta- cells: Possible implication of a pyruvate/citrate shuttle in insulin secretion. Diabetes 2000; 49(5):718-726.
47. Schuit F, De Vos A, Farfari S et al. Metabolic fate of glucose in purified islet cells. Glucose-regulated anaplerosis in beta cells. J Biol Chem 1997; 272(30):18572-18579.
48. Malaisse WJ, Hutton JC, Kawazu S et al. The stimulus-secretion coupling of glucose-induced insulin release. XXXV. The links between metabolic and cationic events. Diabetolog 1979; 16(5):331-341.
49. Newgard CB, McGarry JD. Metabolic coupling factors in pancreatic beta-cell signal transduction. Annu Rev Biochem 1995; 64:689-719.
50. Defronzo RA. Pathogenesis of type-2 diabetes - metabolic and molecular implications for identifying diabetes genes. Diabet Rev 1997; 5(3):177-269.
51. Williams JA. Electrical correlates of secretion in endocrine and exocrine cells. Fed Proc 1981; 40(2):128-134.
52. Rorsman P, Bokvist K, Ammala C et al. Ion channels, electrical activity and insulin secretion. Diabete Metab 1994; 20(2):138-145.
53. Ashcroft FM, Rorsman P. Electrophysiology of the pancreatic beta-cell. Prog Biophys Mol Biol 1989; 54(2).
54. Cook DL, Satin LS, Ashford ML et al. ATP-sensitive K+ channels in pancreatic beta-cells. Spare-channel hypothesis. Diabetes 1988; 37(5):495-498.
55. Loussouarn G, Pike LJ, Ashcroft FM et al. Dynamic sensitivity of ATP-sensitive K(+) channels to ATP. J Biol Chem 2001; 276(31):29098-29103.
56. Song DK, Ashcroft FM. ATP modulation of ATP-sensitive potassium channel ATP sensitivity varies with the type of SUR subunit. J Biol Chem 2001; 276(10):7143-7149.
57. Ashcroft FM, Gribble FM. ATP-sensitive K+ channels and insulin secretion: Their role in health and disease. Diabetolog 1999; 42(8):903-919.
58. Ashcroft FM, Rorsman P. ATP-sensitive K+ channels: A link between B-cell metabolism and insulin secretion. Biochem Soc Trans 1990; 18(1):109-111.
59. Ashcroft SJ, Ashcroft FM. Properties and functions of ATP-sensitive K-channels. Cell Signal 1990; 2(3):197-214.
60. Bryan J, Aguilar-Bryan L. The ABCs of ATP-sensitive potassium channels: More pieces of the puzzle. Curr Opin Cell Biol 1997; 9(4):553-559.
61. Sakura H, Ashcroft FM. Identification of four trpl gene variants murine pancreatic beta-cells. Diabetolog 1997; 40(5):528-532.
62. Gembal M, Detimary P, Gilon P et al. Mechanisms by which glucose can control insulin release independently from its action on adenosine triphosphate-sensitive K+ channels in mouse B cells. J Clin Invest 1993; 91(3):871-880.
63. Gembal M, Gilon P, Henquin JC. Evidence that glucose can control insulin release independently ftom its action on ATP-sensitive K+ channels in mouse B cells. J Clin Invest 1992; 89(4):1288-1295.
64. Komatsu M, Noda M, Sharp GW. Nutrient augmentation of Ca2+-dependent and Ca2+-independent pathways in stimulus-coupling to insulin secretion can be distinguished by their guanosine triphosphate requirements: Studies on rat pancreatic islets. Endocrinology 1998; 139(3):1172-1183.
65. Komatsu M, Schermerhorn T, Noda M et al. Augmentation of insulin release by glucose in the absence of extracellular Ca2+: New insights into stimulus-secretion coupling. Diabetes 1997; 46(12):1928-1938.
66. Komatsu M, Sharp GW, Aizawa T et al. Glucose stimulation of insulin release without an increase in cytosolic free Ca2+ concentration: A possible involvement of GTP. Jpn J Physiol 1997; 47 Suppl 1:S22-S24.
67. Regazzi R, Li G, Ullrich S et al. Different requirements for protein kinase C activation and Ca2+-independent insulin secretion in response to guanine nucleotides. Endogenously generated diacylglycerol requires elevated Ca2+ for kinase C insertion into membranes. J Biol Chem 1989; 264(17):9939-9944.
68. Li GD, Luo RH, Metz SA. Effects of inhibitors of guanine nucleotide synthesis on membrane potential and cytosolic free Ca2+ levels in insulin-secreting cells. Biochem Pharmacol 2000; 59(5):545-556.
69. Babenko AP, Aguilar-Bryan L, Bryan J. A view of sur/KIR6.X, KATP channels. Annu Rev Physiol 1998; 60:667-687.
70. Gribble FM, Reimann F, Ashfield R et al. Regulation of KATP channels by nucleotides and drugs. Meeting of the physiological society, Cambridge, England, UK, July 21-22, 1989. J Physiol (London) 2000; 525P:27S-28S.
71. Suzuki M, Fujikura K, Inagaki N et al. Localization of the ATP-sensitive K+ channel subunit Kir6.2 in mouse pancreas. Diabetes 1997; 46(9):1440-1444.
72. Miki T, Nagashima K, Seino S. The structure and function of the ATP-sensitive K+ channel in insulin-secreting pancreatic beta-cells. J Mol Endocrinol 1999; 22(2):113-123.
73. Bokvist K, Olsen HL, Hoy M et al. Characterisation of sulphonylurea and ATP-regulated K+ channels in rat pancreatic A-cells. Pflug Arch Eur J Physiol 1999; 438(4):428-436.
74. Suzuki M, Fujikura K, Kotake K et al. Immuno-localization of sulphonylurea receptor 1 in rat pancreas. Diabetolog 1999; 42(10):1204-1211.
75. Gopel SO, Kanno T, Barg S et al. Patch-clamp characterisation of somatostatin-secreting delta-cells in intact mouse pancreatic islets. J Physiol (London) 2000; 528(3):497-507.
76. Gopel SO, Kanno T, Barg S et al. Regulation of glucagon release in mouse alpha-cells by K-ATP channels and inactivation of TTX-sensitive Na+ channels. J Physiol -London 2000; 528(3):509-520.
77. Ann K, Kowalchyk JA, Loyet KM et al. Novel Ca2+-binding protein (CAPS) related to UNC-31 required for Ca2+-activated exocytosis. J Biol Chem 1997; 272(32):19637-19640.
78. Bokvist K, Eliasson L, Ammala C et al. Colocalization of L-type Ca2+ channels and insulin-containing secretory granules and its significance for the initiation of exocytosis in mouse pancreatic B-cells. EMBO J 1995; 14(1):50-57.
79. Wiser O, Trus M, Hernandez A et al. The voltage sensitive Lc-type Ca2+ channel is functionally coupled to the exocytotic machinery. Proc Natl Acad Sci USA 1999; 96(1):248-253.
80. Nilius B, Hess P, Lansman JB et al. A novel type of cardiac calcium channel in ventricular cells. Nature 1985; 316(6027):443-446.
81. 2+ Channels. Ion Channels and Disease. San Diego: Academic Press, 2000:161-183.
82. Gutnick MJ, Lux HD, Swandulla D et al. Voltage-dependent and calcium-dependent inactivation of calcium channel current in identified snail neurones. J Physiol (Lond) 1989; 412:197-220.
83. Ammala C, Ashcroft FM, Rorsman P. Calcium-independent potentiation of insulin release by cyclic AMP in single beta-cells. Nature 1993; 363(6427):356-358.
84. Dean PM. Ultrastructural morphometry of the pancreatic -cell. Diabetolog 1973; 9(2):115-119.
85. Eliasson L, Renstrom E, Ding WG et al. Rapid ATP-dependent priming of secretory granules precedes Ca(2+)- induced exocytosis in mouse pancreatic B-cells. J Physiol (Lond) 1997; 503(Pt2):399-412.
86. Rorsman P, Eliasson L, Renstrom E et al. The cell physiology of biphasic insulin secretion. News Physiol Sci 2000; 15:72-77.
87. Gromada J, Hoy M, Renstrom E et al. CaM kinase II-dependent mobilization of secretory granules underlies acetylcholine-induced stimulation of exocytosis in mouse pancreatic B-cells. J Physiol (Lond) 1999; 518(Pt 3):745-759.
88. Ammala C, Eliasson L, Bokvist K et al. Activation of protein kinases and inhibition of protein phosphatases play a central role in the regulation of exocytosis in mouse pancreatic beta cells. Proc Natl Acad Sci USA 1994; 91(10):4343-4347.
89. Wasmeier C, Hutton JC. Secretagogue-dependent phosphorylation of the insulin granule membrane protein phogrin is mediated by cAMP-dependent protein kinase. J Biol Chem 2001; 276(34):31919-31928.
90. Wasmeier C, Hutton JC. Secretagogue-dependent phosphorylation of phogrin, an insulin granule membrane protein tyrosine phosphatase homologue. Biochem J 1999; 341(Pt3):563-569.
91. Rorsman P. The pancreatic beta-cell as a fuel sensor: An electrophysiologist's viewpoint. Diabetolog 1997; 40(5):487-495.
92. Huang JD, Brady ST, Richards BW et al. Direct interaction of microtubule- and actin-based transport motors. Nature 1999; 397(6716):267-270.
93. Easom RA. beta-granule transport and exocytosis. Semin Cell Dev Biol 2000; 11(4):253-266.
94. Sollner T, Bennett MK, Whiteheart SW et al. A protein assembly-disassembly pathway in vitro that may correspond to sequential steps of synaptic vesicle docking, activation, and fusion. Cell 1993; 75(3):409-418.
95. Rupnik M, Kreft M, Sikdar SK et al. Rapid regulated dense-core vesicle exocytosis requires the CAPS protein. Proc Natl Acad Sci USA 2000; 97(10):5627-5632.
96. Jahn R, Sudhof TC. Membrane fusion and exocytosis. Annu Rev Biochem 1999; 68:863-911.
97. Jacobsson G, Bean AJ, Scheller RH et al. Identification of synaptic proteins and their isoform mRNAs in compartments of pancreatic endocrine cells. Proc Natl Acad Sci USA 1994; 91(26):12487-12491.
98. Lang J. Molecular mechanisms and regulation of insulin exocytosis as a paradigm of endocrine secretion. Eur J Biochem 1999; 259(1-2):3-17.
99. Lao GF, Scheuss V, Gerwin CM et al. Syntaphilin: A syntaxin-1 clamp that controls SNARE assembly. Neuron 2000; 25(1):191-201.
100. Fisher RJ, Pevsner J, Burgoyne RD. Control of fusion pore dynamics during exocytosis by Munc18. Science 2001; 291(5505):875-878.
101. Huang X, Kang YH, Pasyk EA et al. Ca(2+) influx and cAMP elevation overcame botulinum toxin A but not tetanus toxin inhibition of insulin exocytosis. Am J Physiol Cell Physiol 2001; 281(3):C740-C750.
102. Land J, Zhang H, Vaidyanathan VV et al. Transient expression of botulinum neurotoxin Cl light chain differentially inhibits calcium and glucose induced insulin secretion in clonal beta-cells. Febs Lett 1997; 419(1):13-17.
103. Li C, Ullrich B, Zhang JZ et al. Ca(2+)-dependent and -independent activities of neural and nonneural synaptotagmins. Nature 1995; 375(6532):594-599.
104. Loyet KM, Kowalchyk JA, Chaudhary A et al. Specific binding of phosphatidylinositol 4,5-bisphosphate to calcium-dependent activator protein for secretion (CAPS), a potential phosphoinositide effector protein for regulated exocytosis. J Biol Chem 1998; 273(14):8337-8343.
105. Sollner T, Bennett MK, Whiteheart SW et al. A protein assembly-disassembly pathway in vitro that may correspond to sequential steps of synaptic vesicle docking, activation and fusion. Cell 1993; 75(3):409-418.
106. Xu T, Rammner B, Margittai M et al. Inhibition of SNARE complex assembly differentially affects kinetic components of exocytosis. Cell 1999; 99(7):713-722.
107. Xu T, Ashery U, Burgoyne RD et al. Early requirement for alpha-SNAP and NSF in the secretory cascade in chromaffin cells. EMBO J 1999; 18(12):3293-3304.
108. Iezzi M, Escher G, Meda P et al. Subcellular distribution and function of Rab3A, B, C, and D isoforms in insulin-secreting cells. Mol Endocrinol 1999; 13(2):202-212.
109. Kajio H, Olszewski S, Rosner PJ et al. A low-affinity Ca2+-dependent association of calmodulin with the Rab3A effector domain inversely correlates with insulin exocytosis. Diabetes 2001; 50(9):2029-2039.
110. Balsinde J, Balboa MA, Insel PA et al. Regulation and inhibition of phospholipase A2. Annu Rev Pharmacol Toxicol 1999; 39:175-189.
111. Lai MM, Hong JJ, Ruggiero AM et al. The calcineurin-dynamin 1 complex as a calcium sensor for synaptic vesicle endocytosis. J Biol Chem 1999; 274(37):25963-25966.
112. Bauerfeind R, Takei K, De Camilli P. Amphiphysin I is associated with coated endocytic intermediates and undergoes stimulation-dependent dephosphorylation in nerve terminals. J Biol Chem 1997; 272(49):30984-30992.
113. Renstrom E, Eliasson L, Rorsman P. Protein kinase A-dependent and -independent stimulation of exocytosis by cAMP in mouse pancreatic B-cells. J Physiol (Lond) 1997; 502(Pt 1):105-118.
114. Holz GG, Leech CA, Scott-Heller R et al. cAMP-dependent mobilization of intracellular Ca2+ stores by activation of ryanodine receptors in pancreatic beta-cells. J Biol Chem 1999; 274(20):14147-14156.
115. Ashcroft FM, Proks P, Smith PA et al. Stimulus-secretion coupling in pancreatic beta cells. J Cell Biochem 1994; 55(Suppl):54-65.
116. Corkey BE, Deeney JT, Yaney GC et al. The role of long-chain fatty acyl-CoA esters in beta-cell signal transduction. J Nutr 2000; 130(25 Suppl):299S-304S.
117. McPhail LC, Clayton CC, Snyderman R. A potential second messenger role for unsaturated fatty acids: Activation of Ca2+-dependent protein kinase. Science 1984; 224(4649):622-625.
118. Murakami K, Chan SY, Routtenberg A. Protein kinase C activation by cis-fatty acid in the absence of Ca2+ and phospholipids. J Biol Chem 1986; 261(33):15424-15429.
119. Prescott SM. A thematic series on phospholipases. J Biol Chem 1997; 272(24):15043.
120. Tischfield JA. A reassessment of the low molecular weight phospholipase A2 gene family in mammals. J Biol Chem 1997; 272(28):17247-17250.
121. Clark JD, Lin LL, Kriz RW et al. A novel arachidonic acid-selective cytosolic PLA2 contains a Ca(2+)-dependent translocation domain with homology to PKC and GAP. Cell 1991; 65(6):1043-1051.
122. Sharp JD, White DL, Chiou XG et al. Molecular cloning and expression of human Ca(2+)-sensitive cytosolic phospholipase A2. J Biol Chem 1991; 266(23):14850-14853.
123. Leslie CC. Properties and regulation of cytosolic phospholipase A2. J Biol Chem 1997; 272(27):16709-16712.
124. Sapirstein A, Bonventre JV. Specific physiological roles of cytosolic phospholipase A2 as defined by gene knockouts. Biochim Biophys Acta 2000; 1488(1-2):139-148.
125. Bonventre JV, Huang Z, Taheri MR et al. Reduced fertility and postischaemic brain injury in mice deficient in cytosolic phospholipase A2. Nature 1997; 390(6660):622-625.
126. Murakami M, Nakatani Y, Kuwata H et al. Cellular components that functionally interact with signaling phospholipase A2s. Biochim Biophys Acta 2000; 1488(1-2):159-166.
127. Balsinde J, Dennis EA. Function and inhibition of intracellular calcium-independent phospholipase A2. J Biol Chem 1997; 272(26):16069-16072.
128. Winstead MV, Balsinde J, Dennis EA. Calcium-independent phospholipase A(2): Structure and function. BBA-Mol Cell Biol Lipids 2000; 1488(1-2):28-39.
129. Ramanadham S, Hsu FF, Bohrer A et al. Studies of the role of group VI phospholipase A2 in fatty acid incorporation, phospholipid remodeling, lysophosphatidylcholine generation, and secretagogue-induced arachidonic acid release in pancreatic islets and insulinoma cells. J Biol Chem 1999; 274(20):13915-13927.
130. Dennis EA. The growing phospholipase A2 superfamily of signal transduction enzymes. Trends Biochem Sci 1997; 22(1):1-2.
131. Stafforini DM, McIntyre TM, Zimmerman GA et al. Platelet-activating factor acetylhydrolases. J Biol Chem 1997; 272(29):17895-17898.
132. Ramanadham S, Ma Z, Arita H et al. Type IB secretory phospholipase A2 is contained in insulin secretory granules of pancreatic islet beta-cells and is co secreted with insulin from glucose-stimulated islets. Biochim Biophys Acta 1998; 1390(3):301-312.
133. Metz S, Holmes D, Robertson RP et al. Gene expression of type I phospholipase A2 in pancreatic beta cells. Regulation of mRNA levels by starvation or glucose excess. Febs Lett 1991; 295(1-3):110-112.
134. Loweth AC, Scarpello JH, Morgan NG. Phospholipase A2 expression in human and rodent insulin-secreting cells published erratum appears in Mol Cell Endocrinol 1995 Oct 30; 114(1-2):227-8. Mol Cell Endocrinol 1995; 112(2):177-183.
135. Niwa T, Matsukawa Y, Senda T et al. Acetylcholine activates intracellular movement of insulin granules in pancreatic beta-cells via inositol trisphosphate-dependent correction of triphosphate-dependent mobilization of intracellular Ca2+ [published erratum appears in Diabetes 1999; 48(1):233]. Diabetes 1998; 47(11):1699-1706.
136. Parker KJ, Jones PM, Hunton CH et al. Identification and localisation of a type IV cytosolic phospholipase A2 in rat pancreatic beta-cells. J Mol Endocrinol 1996; 17(1):31-43.
137. Eddlestone GT. ATP-sensitive K channel modulation by products of PLA2 action in the insulin-secreting HIT cell line. Am J Physiol Cell Physiol 1995; 268(1 37-1):C181-C190.
138. Ramanadham S, Gross RW, Han X et al. Inhibition of arachidonate release by secretagogue-stimulated pancreatic islets suppresses both insulin secretion and the rise in beta-cell cytosolic calcium ion concentration. Biochemistry (Mosc) 1993; 32(1):337-346.
139. Gross RW, Ramanadham S, Kruszka KK et al. Rat and human pancreatic islet cells contain a calcium ion independent phospholipase A2 activity selective for hydrolysis of arachidonate which is stimulated by adenosine triphosphate and is specifically localized to islet beta- cells. Biochemistry (Mosc) 1993; 32(1):327-336.
140. Kashiwagi M, Friess H, Uhl W et al. Phospholipase A2 isoforms are altered in chronic pancreatitis. Ann Surg 1998; 227(2):220-228.
141. Seeds MC, Jones DF, Chilton FH et al. Secretory and cytosolic phospholipases A2 are activated during TNF priming of human neutrophils. Biochim Biophys Acta 1998; 1389(3):273-284.
142. Turk J, Wolf BA, Lefkowith JB et al. Glucose-induced phospholipid hydrolysis in isolated pancreatic islets: Quantitative effects on the phospholipid content of arachidonate and other fatty acids. Biochim Biophys Acta 1986; 879(3):399-409.
143. Ma Z, Ramanadham S, Kempe K et al. Pancreatic islets express a Ca2+-independent phospholipase A2 enzyme that contains a repeated structural motif homologous to the integral membrane protein binding domain of ankyrin. J Biol Chem 1997; 272(17):11118-11127.
144. Ramanadham S, Hsu FF, Bohrer A et al. Electrospray ionization mass spectrometric analyses of phospholipids from rat and human pancreatic islets and subcellular membranes: Comparison to other tissues and implications for membrane fusion in insulin exocytosis. Biochemistry (Mosc) 1998; 37(13):4553-4567.
145. Wolf BA, Turk J, Sherman WR et al. Intracellular Ca2+ mobilization by arachidonic acid. Comparison with myo- inositol 1,4,5-trisphosphate in isolated pancreatic islets. J Biol Chem 1986; 261(8):3501-3511.
146. Wolf BA, Pasquale SM, Turk J. Free fatty acid accumulation in secretagogue-stimulated pancreatic islets and effects of arachidonate on depolarization-induced insulin secretion. Biochemistry (Mosc) 1991; 30(26):6372-6379.
147. Bell RL, Kennerly DA, Stanford N et al. Diglyceride lipase: A pathway for arachidonate release from human platelets. Proc Natl Acad Sci USA 1979; 76(7):3238-3241.
148. Konrad RJ, Major CD, Wolf BA. Diacylglycerol hydrolysis to arachidonic acid is necessary for insulin secretion from isolated pancreatic islets: Sequential actions of diacylglycerol and monoacylglycerol lipases. Biochemistry (Mosc) 1994; 33(45):13284-13294.
149. Konrad RJ, Jolly YC, Major C et al. Inhibition of phospholipase A2 and insulin secretion in pancreatic islets. Biochim Biophys Acta 1992; 1135(2):215-220.
150. Metz SA. Pancreatic islet phospholipase A2: Differential, Ca2+-dependent effects of lysophospholipids, arachidonic acid, and its lipoxygenase-derived metabolites on insulin release. Adv Prostaglandin Thromboxane Leukot Res 1987; 178:668-676.
151. Shuttleworth TJ. Arachidonic acid activates the noncapacitative entry of Ca2+ during Ca2+i oscillations. J Biol Chem 1996; 271(36):21720-21725.
152. Damron DS, Van-Wagoner DR, Moravec CS et al. Arachidonic acid and endothelin potentiate Ca2+ transients in rat cardiac myocytes via inhibition of distinct K+ channels. J Biol Chem 1993; 268(36):27335-27344.
153. Graber MN, Alfonso A, Gill DL. Ca2+ pools and cell growth: Arachidonic acid induces recovery of cells growth-arrested by Ca2+ pool depletion. J Biol Chem 1996; 271(2):883-888.
154. McPhail LC, Clayton CC, Snyderman R. A potential second messenger role for unsaturated fatty acids: Activation of Ca2+-dependent protein kinase. Science 1984; 224(4649):622-625.
155. Metz SA. Exogenous arachidonic acid promotes insulin release from intact or permeabilized rat islets by dual mechanisms. Putative activation of Ca2+ mobilization and protein kinase C. Diabetes 1988; 37(11):1453-1469.
156. Metz SA. The pancreatic islet as Rubik's Cube. Is phospholipid hydrolysis a piece of the puzzle? Diabetes 1991; 40(12):1565-1573.
157. Ramanadham S, Gross R, Turk J. Arachidonic acid induces an increase in the cytosolic calcium concentration in single pancreatic islet beta cells. Biochem Biophys Res Commun 1992; 184(2):647-653.
158. 157a. Juhl K, Hoy M, Olsen HL et al. cPLA2alpha-evoked formation of arachidonic acid and lysophospholipids is required for exocytosis in mouse pancreatic beta-cells. Am J Physiol Endocrinol Metab 2003; 285(1):E73-81.
159. Hirabayashi T, Shimizu T. Localization and regulation of cytosolic phospholipase A2. Biochim Biophys Acta 2000; 1488(1-2):124-138.
160. Kato R, Yamamoto S, Nakadate T et al. Possible involvement of phospholipase A2 activation and lipoxygenase product(s) in the mechanism of insulin secretion. Adv Prostaglandin Thromboxane Leukot Res 1983; 12:265-270.
161. Zhou YP, Teng D, Dralyuk F et al. Apoptosis in insulin-secreting cells. Evidence for the role of intracellular Ca2+ stores and arachidonic acid metabolism. J Clin Invest 1998; 101(8):1623-1632.
162. Ma Z, Ramanadham S, Corbett JA et al. Interleukin-1 enhances pancreatic islet arachidonic acid 12- lipoxygenase product generation by increasing substrate availability through a nitric oxide-dependent mechanism. J Biol Chem 1996; 271(2):1029-1042.
163. Metz SA. Mobilization of cellular Ca2+ by lysophospholipids in rat islets of Langerhans. Biochim Biophys Acta 1988; 968(2):239-252.
164. Rustenbeck I, Lenzen S. Effect of lysophospholipids, arachidonic acid and other fatty acids on regulation of Ca2+ transport in permeabilized pancreatic islets. Cell Calcium 1992; 13(4):193-202.
165. Gasser KW, Holda JR. ATP-sensitive potassium transport by pancreatic secretory granule membrane. Am J Physiol 1993; 264(1 Pt 1):G137-G142.
166. Metz SA. Ether-linked lysophospholipids initiate insulin secretion. Lysophospholipids may mediate effects of phospholipase A2 activation on hormone release. Diabetes 1986; 35(7):808-817.
167. Frossard JL, Bhagat L, Lee HS et al. Both thermal and nonthermal stress protect against caerulein induced pancreatitis and prevent trypsinogen activation in the pancreas. Gut 2002; 50(1):78-83.
168. Ramsingh AI, Chapman N, Tracy S. Coxsackieviruses and diabetes. Bioessays 1997; 19(9):793-800.
169. Sevilla N, Homann D, von Herrath M et al. Virus-induced diabetes in a transgenic model: Role of cross-reacting viruses and qualification of effector T cells needed to cause disease. J Virol 2000; 74(7):3284-3292.
170. Gu D, Sarvetnick N. Epithelial cell proliferation and islet neogenesis in IFN-g transgenic mice. Development 1993; 118(1):33-46.
171. Pruzanski W, Vadas P. Phospholipase A2 - a mediator between proximal and distal effectors of inflammation. Immunol Today 1991; 12(5):143-146.
172. van Puijenbroek AA, Wissink S, van der Saag PT et al. Phospholipase A2 inhibitors and leukotriene synthesis inhibitors block TNF-induced NF-kappaB activation. Cytokine 1999; 11(2):104-110.
173. Roe MW, Worley JF, Qian F et al. Characterization of a Ca2+ release-activated nonselective cation current regulating membrane potential and [Ca2+]i oscillations in transgenically derived beta-cells. J Biol Chem 1998; 273(17):10402-10410.
174. Nalefski EA, Falke JJ. The C2 domain calcium-binding motif: Structural and functional diversity. Protein Sci 1996; 5(12):2375-2390.
175. Bottomley MJ, Salim K, Panayotou G. Phospholipid-binding protein domains. Biochim Biophys Acta 1998; 1436(1-2):165-183.
176. Six DA, Dennis EA. The expanding superfamily of phospholipase A2 enzymes: Classification and characterization. Biochim Biophys Acta 2000; 1488(1-2):1-19.